Department of Medicine

September 18, 2014

Prevention key to fight familial hypercholesterolemia

Imagine an inherited cause of early heart attacks that is more common than type-1 diabetes, multiple sclerosis or cystic fibrosis, but goes largely unrecognized.

By Matt Batcheldor
September 18, 2014

State public health award named for Schaffner

The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.

By Craig Boerner
September 4, 2014

Lung cancer study reveals new drug combination targets

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.

By VUMC News and Communications
Cholesterol
August 21, 2014

Major grant spurs deeper look into ‘good cholesterol’

In some cases, HDL, the “good cholesterol,” may not function properly and may actually accelerate atherosclerosis.

By Bill Snyder
August 21, 2014

Study in East Asians identifies genes tied to colon cancer risk

Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.

By VUMC News and Communications
flu shot
August 13, 2014

High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.

By Craig Boerner
August 7, 2014

Medical Scholars Program sees success

Applicants to the Vanderbilt Medical Scholars Program, a yearlong, in-depth research experience, have been successful in obtaining both internal and external research funding this year.
By Jessica Pasley
July 31, 2014

VICC investigators land Komen breast cancer research grants

Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation.
By VUMC News and Communications
July 31, 2014

Photo: Summer research conference

Undergraduates from across the country attended a summer research conference at Vanderbilt this week sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.
By VUMC News and Communications
July 24, 2014

Gene study focuses on breast cancer in East Asian women

A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics.
By VUMC News and Communications
July 17, 2014

Lovly’s research bolstered by lung cancer foundation

The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology.
By VUMC News and Communications
July 17, 2014

VICC’s Abramson lands breast cancer clinical research award

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF).
By VUMC News and Communications
July 10, 2014

Molecular ‘chat’ holds kidney fibrosis clues

A novel molecular “conversation” regulates kidney fibrosis – the final result of end-stage chronic kidney disease – suggesting new treatment options for this currently irreversible process.
By Leigh MacMillan